News Focus
News Focus
icon url

BigE1960

07/08/19 8:35 AM

#75181 RE: drugmanrx #75180

The point is perspective. Minimums (a couple hundred thousand dollars per year) are essentially insignificant.
icon url

BigE1960

07/08/19 8:48 AM

#75183 RE: drugmanrx #75180

Original position:

QTMM will receive recurring revenue for quantum dots used by Amtronics for every research project whether it be a success or failure.

If this refers to the annual minimum payment schedule. There is no dispute. However, the minimals exist regardless of dots produced or research projects conducted so I think most will see this as a new "minimums" argument and a shifting of the goalposts.